Document Detail

Shock in acute myocardial infarction: the Cape Horn for trials?
MedLine Citation:
PMID:  20610640     Owner:  NLM     Status:  In-Process    
Despite therapeutic improvements, cardiogenic shock (CS) remains the most common cause of death in patients with acute myocardial infarction (AMI). In addition to percutaneous coronary intervention, inotropes, fluids, adjunctive medication, intra-aortic balloon counterpulsation, and also assist devices are widely used for treatment. However, currently, there is only limited evidence for any of the above treatments. This review will therefore outline the underlying causes, pathophysiology, and treatment of CS complicating AMI with major focus on interventional techniques and advancement of new therapeutical arsenals, both pharmacological and mechanical.
Holger Thiele; Bachir Allam; Gilles Chatellier; Gerhard Schuler; Antoine Lafont
Publication Detail:
Type:  Journal Article     Date:  2010-07-07
Journal Detail:
Title:  European heart journal     Volume:  31     ISSN:  1522-9645     ISO Abbreviation:  Eur. Heart J.     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-08-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  England    
Other Details:
Languages:  eng     Pagination:  1828-35     Citation Subset:  IM    
Department of Internal Medicine/Cardiology, University of Leipzig-Heart Center, Strümpellstrasse 39, Leipzig, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Appropriate research designs for evaluating community-level alcohol interventions: what next?
Next Document:  TNF, but Not IL-6 and IL-17, Is Crucial for the Development of T Cell-Independent Psoriasis-Like Der...